Insights › Likitanci da magunguna › November 16, 2026
Likitanci da magunguna · Ayyukan da ake kan yi da ci gaba

Novo ta Gabatar da Bayanan Gwajin Farko da Na Mutane Wanda ke Nuna Matsayin Kunna Karɓar Amylin da Calcitonin wajen Kare Ƙasusuwa Yayin Rage Nauyi a ObesityWeek®

PR Newswire (Health) An wallafa: Results

Maganin da ake bincike na CagriSema da cagrilintide na kamfanin Novo sun rage asarar ƙasusuwa a cikin samfurin gwajin farko na menopause¹ A cikin ƙananan binciken da aka gudanar a kan mutane, masu tayar da karɓar amylin da calcitonin guda biyu, cagrilintide da zenagamtide, amma ba mai zaɓar karɓar amylin NN1213 ba, sun kasance...

Asalin tushe
Karanta tushen — prnewswire.com ↗

Muna haɗawa da ainihin mai wallafawa. Taƙaitawar da ke sama jagora ce kawai; karanta asalin don cikakken bayani.

Ƙari a Likitanci da magunguna

Duba komai a cikin Likitanci da magunguna →

Ƙara bincika wannan batu

Karanta kowane bayani da yarenka

Wannan shafi yana nuna sabbin abubuwa uku ne kawai a kowane fanni. Mambobi na ganin kowane bayani a cikin fannin, a harsuna 109, tare da injinan bincike da ke aiki a kansu.

Karanta duka — fara daga $3Babu buƙatar shigarwa daga kantin manhajoji. Ana iya soke shi kowane lokaci.